{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T13:35:51Z","timestamp":1771076151962,"version":"3.50.1"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T00:00:00Z","timestamp":1576713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2019.01462","type":"journal-article","created":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T08:44:06Z","timestamp":1576831446000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Limited Associations Between 5-HT Receptor Gene Polymorphisms and Treatment Response in Antidepressant Treatment-Free Patients With Depression"],"prefix":"10.3389","volume":"10","author":[{"given":"Taichi","family":"Ochi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalya M.","family":"Vyalova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Innokentiy S.","family":"Losenkov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana Z.","family":"Paderina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan V.","family":"Pozhidaev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton J. M.","family":"Loonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"German G.","family":"Simutkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolay A.","family":"Bokhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svetlana A.","family":"Ivanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bob","family":"Wilffert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,12,19]]},"reference":[{"key":"B1","first-page":"1","article-title":"Neuronal 5-HT receptors and SERT","volume":"34","author":"Barnes","year":"2011","journal-title":"Tocris Biosci. Sci. Rev. Ser."},{"key":"B2","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3109\/15622975.2013.804195","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders","volume":"14","author":"Bauer","year":"2013","journal-title":"World J. Biol. Psychiatry"},{"key":"B3","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3109\/15622975.2014.1001786","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders. Part 2: maintenance treatment of major depressive disorder-update 2015","volume":"16","author":"Bauer","year":"2015","journal-title":"World J. Biol. Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fphar.2014.00068","article-title":"Neuronallocalization of the 5-HT2 receptor family in the amygdaloid complex","volume":"5","author":"Bombardi","year":"2014","journal-title":"Front. Pharmacol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3109\/15622975.2010.546428","article-title":"Genetics in psychiatry: are the promises met","volume":"12","author":"Bondy","year":"2011","journal-title":"World J. Biol. Psychiatry"},{"key":"B6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.2174\/156802606778522131","article-title":"Serotonin 5-HT2A and 5-HT2C receptors as potential targets for modulation of psychostimulant use and dependence","volume":"6","author":"Bubar","year":"2006","journal-title":"Curr. Topics Med. Chem."},{"key":"B7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/387303a0","article-title":"Regulation of serotonin-2C receptor G-protein coupling by RNA editing","volume":"387","author":"Burns","year":"1997","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.pnpbp.2015.12.006","article-title":"5-HT2C receptors in psychiatric disorders: a review","volume":"66","author":"Chagraoui","year":"2016","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4172\/2167-065x.1000110","article-title":"759C\/T Variants of the serotonin (5-HT2C) receptor gene and weight gain in children and adolescents in long-term risperidone treatment","volume":"2","author":"Del Castillo","year":"2013","journal-title":"Clin. Pharmacol. Biopharm."},{"key":"B12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.pharmthera.2017.07.014","article-title":"The central serotonin 2B receptor as a new pharmacological target for the treatment of dopamine-related neuropsychiatric disorders: rationale and current status of research","volume":"181","author":"Devroye","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"B9","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/978-1-60761-941-3","volume-title":"5HT2C Receptors in the Pathophysiology of CNS Disease","author":"Di Giovanni","year":"2011"},{"key":"B13","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/bf03193146","article-title":"G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav. Res. Methods"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3758\/brm.41.4.1149","article-title":"Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses","volume":"41","author":"Faul","year":"2009","journal-title":"Behav. Res. Methods"},{"key":"B15","first-page":"4","article-title":"Mechanism of action of antidepressant medications","volume":"60","author":"Feighner","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"B16","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1124\/pr.107.07103","article-title":"5-HT receptor regulation of neurotransmitter release","volume":"59","author":"Fink","year":"2007","journal-title":"Pharmacol. Rev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"3604","DOI":"10.1111\/bph.12720","article-title":"Agomelatine: mechanism of action and pharmacological profile in relation to antidepressant properties","volume":"171","author":"Guardiola-Lemaitre","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/sim.4780030207","article-title":"Regression modelling strategies for improved prognostic prediction","volume":"3","author":"Harrell","year":"1984","journal-title":"Stat. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.tips.2013.08.001","article-title":"From obesity to substance abuse: therapeutic opportunities for 5-HT 2C receptor agonists","volume":"34","author":"Higgins","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/15622975.2016.1224926","article-title":"Identification of 5-hydroxytryptamine receptor gene polymorphisms modulating hyperprolactinaemia in antipsychotic drug-treated patients with schizophrenia","volume":"18","author":"Ivanova","year":"2017","journal-title":"World J. Biol. Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1146\/annurev-publhealth-031912-114409","article-title":"The Epidemiology of Depression Across Cultures","volume":"34","author":"Kessler","year":"2013","journal-title":"Annu. Rev. Public Health"},{"key":"B22","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/S2215-0366(16)30263-2","article-title":"Why is depression more common among women than among men?","volume":"4","author":"Kuehner","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2174\/1568007043482598","article-title":"5-HT2 Receptors","volume":"3","author":"Leysen","year":"2004","journal-title":"Curr. Drug Target -CNS Neurol. Disord."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnhum.2016.00571","article-title":"Circuits regulating pleasure and happiness\u2014mechanisms of depression","volume":"10","author":"Loonen","year":"2016","journal-title":"Front. Hum. Neurosci."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2019-0100","article-title":"Putative role of pharmacogenetics to elucidate the mechanism of tardive dyskinesia in schizophrenia","author":"Loonen","year":"2019","journal-title":"Pharmacogenomics"},{"key":"B24","article-title":"Validation of biomarkers in depression: association between BDNF gene variant rs6265 and the severity of depression in antidepressant drug-na\u00efve depressed patients","author":"Losenkov","year":""},{"key":"B25","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/s0736-5748(01)00022-3","article-title":"Developmentally regulated serotonin 5-HT2B receptors","volume":"19","author":"Nebigil","year":"2001","journal-title":"Int. J. Dev. Neurosci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jad.2019.08.058","article-title":"Investigating the potential role of BDNF and PRL genotypes on antidepressant response in depression patients: a prospective inception cohort study in treatment-free patients","volume":"259","author":"Ochi","year":"2019","journal-title":"J. Affect. Disord."},{"key":"B27","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/ajmg.b.20143","article-title":"A 5-HT2C receptor promoter polymorphism (HTR2C-759C\/T) is associated with obesity in women, and with resistance to weight loss in heterozygotes","author":"Pooley","year":"2004","journal-title":"Am. J. Med. Genet."},{"key":"B35","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.00063","article-title":"5-Hydroxytryptamine receptors and tardive dyskinesia in schizophrenia","author":"Pozhidaev","year":""},{"key":"B28","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/bcp.12312","article-title":"Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms","volume":"77","author":"Reynolds","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/978-0-387-79251-4_14","article-title":"Pharmacogenetics of antidepressant response","volume":"3","author":"Serretti","year":"2009","journal-title":"Biomarkers Psychiatr. Disord."},{"key":"B30","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s11199-005-6762-3","article-title":"Gender differences in self-reports of depression: the response bias hypothesis revisited","volume":"53","author":"Sigmon","year":"2005","journal-title":"Sex Roles"},{"key":"B31","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1159\/000487484","article-title":"Association of polymorphisms of serotonin transporter (5HTTLPR) and 5-HT2C receptor genes with criminal behavior in Russian criminal offenders","volume":"75","author":"Toshchakova","year":"2018","journal-title":"Neuropsychobiology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1016\/s0024-3205(03)00141-3","article-title":"5-HT2A and 5-HT2C receptors and their atypical regulation properties","volume":"72","author":"Van Oekelen","year":"2003","journal-title":"Life Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13041-017-0306-y","article-title":"The role of 5-HT receptors in depression","volume":"10","author":"Yohn","year":"2017","journal-title":"Mol. Brain"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.01462\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,9]],"date-time":"2022-10-09T03:29:38Z","timestamp":1665286178000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.01462\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,19]]},"references-count":36,"alternative-id":["10.3389\/fphar.2019.01462"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2019.01462","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,19]]},"article-number":"1462"}}